Development of a Procedure for Identification of Biperiden Hydrochloride with Specificity for Triperiden Hydrochloride

N. E. Kuz’mina; S. V. Moiseev; V. I. Krylov; A. A. Kutin; V. A. Yashkir; V. A. Merkulov

doi:10.1007/s11094-018-1749-x

Development of a Procedure for Identification of Biperiden Hydrochloride with Specificity for Triperiden Hydrochloride

Авторлар: Kuz’mina N.E.¹, Moiseev S.V.¹, Krylov V.I.¹, Kutin A.A.¹, Yashkir V.A.¹, Merkulov V.A.¹
Мекемелер:
1. Scientific Center for Expert Evaluation of Medical Products, Ministry of Health of the Russian Federation
Шығарылым: Том 51, № 12 (2018)
Беттер: 1106-1110
Бөлім: Article
URL: https://ogarev-online.ru/0091-150X/article/view/244931
DOI: https://doi.org/10.1007/s11094-018-1749-x
ID: 244931

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат
Рұқсат жабық

Рұқсат берілді
Рұқсат жабық

Тек жазылушылар үшін

Аннотация
Авторлар туралы
Әдебиет тізімі
Қосымша файлдар
Статистика

Аннотация

Biperiden hydrochloride, (1RS)-1-[(1RS, 2SR, 4RS)-bicyclo[2.2.1]hept-5-en-2-yl]-1-phenyl-3-(piperidin-1-yl)prop an-1-ol hydrochloride, is one of the most efficacious cholinolytics. It is used to treat Parkinson’s disease and various types of muscular spasms and to ameliorate uncoordinated muscular movements that can accompany the use of several tranquilizers [1, 2]. Biperiden appears in the vital and essential drug list that was approved by an order of the RF Government [3].